The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice.
MRD
NGS
NHL
PCR
QT-PCR
digital PCR
lymphoma
minimal residual disease
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
01
2019
accepted:
31
05
2019
entrez:
12
7
2019
pubmed:
12
7
2019
medline:
12
7
2019
Statut:
epublish
Résumé
Minimal residual disease (MRD) in non-Hodgkin's lymphomas (NHLs) still represents matter of interest and debate: indeed, the new available treatments offer higher rates of complete responses and MRD negativity than in the past, with a positive impact on the long-term survival. Furthermore, the introduction of more sensitive and accurate molecular techniques, such as digital PCR (ddPCR) and the next generation sequencing techniques (NGS), increased the possibility of identifying molecular targets to be followed after therapy (such as rearrangement of immunoglobulins, fusion genes, or mutations). This review focused on how molecular biology can help to detect MRD in different types of NHLs and how MRD can change the clinical practice in 2019. In follicular lymphoma (FL), contamination of the grafts and molecular disease persistence after transplantation represent a negative prognostic factors. The combination of Rituximab or Obinutuzumab with Bendamustine seems to be the most effective way to clear MRD in FL patients receiving chemo-immunotherapy (further studies are in progress), and also
Identifiants
pubmed: 31293969
doi: 10.3389/fonc.2019.00528
pmc: PMC6606710
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
528Références
Br J Haematol. 1999 Apr;105(1):190-7
pubmed: 10233383
Leuk Res. 1999 Oct;23(10):921-9
pubmed: 10573138
Leukemia. 1999 Dec;13(12):1901-28
pubmed: 10602411
Leukemia. 2000 Sep;14(9):1563-9
pubmed: 10995001
Blood. 2002 Feb 1;99(3):856-62
pubmed: 11806987
Leukemia. 2002 Sep;16(9):1852-6
pubmed: 12200703
J Clin Pathol. 2003 Feb;56(2):129-32
pubmed: 12560392
Bone Marrow Transplant. 2003 Jul;32(1):57-63
pubmed: 12815479
Leukemia. 1992 Nov;6(11):1213-9
pubmed: 1434806
J Clin Oncol. 2004 Apr 15;22(8):1460-8
pubmed: 15084619
Blood. 2004 Sep 1;104(5):1258-65
pubmed: 15126323
Neoplasma. 2004;51(3):159-63
pubmed: 15254666
Blood. 2005 Aug 15;106(4):1376-81
pubmed: 15860666
Blood. 2006 Mar 15;107(6):2271-8
pubmed: 16332971
Blood. 2006 Jun 1;107(11):4563-9
pubmed: 16449533
Blood. 2007 Mar 1;109(5):1857-61
pubmed: 17105812
Leuk Res. 2008 Jan;32(1):25-32
pubmed: 17320171
Blood. 2008 Jan 15;111(2):558-65
pubmed: 17962512
Haematologica. 2008 Mar;93(3):431-8
pubmed: 18268286
Bone Marrow Transplant. 2009 May;43(9):701-8
pubmed: 19029963
Genes Chromosomes Cancer. 1991 Mar;3(2):117-21
pubmed: 1906343
J Clin Oncol. 2009 Mar 20;27(9):1492-501
pubmed: 19224851
J Hematol Oncol. 2009 Feb 27;2:11
pubmed: 19250532
J Clin Oncol. 2009 Sep 20;27(27):4555-62
pubmed: 19652063
Blood. 2010 Apr 22;115(16):3215-23
pubmed: 20032498
J Nucl Med. 1991 Apr;32(4):686-91
pubmed: 2013808
J Clin Oncol. 2010 May 1;28(13):2246-52
pubmed: 20368567
Clin Ter. 2010;161(3):253-8
pubmed: 20589357
Blood Rev. 2011 Mar;25(2):91-6
pubmed: 21269744
Ann Oncol. 2012 Jan;23(1):147-53
pubmed: 21460380
Br J Haematol. 2011 Jun;153(6):758-63
pubmed: 21496005
N Engl J Med. 2011 Jun 16;364(24):2305-15
pubmed: 21663470
Br J Haematol. 2012 Feb;156(3):346-53
pubmed: 22145911
Expert Opin Biol Ther. 2012 Mar;12(3):343-51
pubmed: 22283718
Leukemia. 2012 Oct;26(10):2159-71
pubmed: 22918122
N Engl J Med. 2012 Aug 30;367(9):826-33
pubmed: 22931316
Lancet Oncol. 2012 Dec;13(12):1250-9
pubmed: 23168367
Lancet. 2013 Apr 6;381(9873):1203-10
pubmed: 23433739
J Clin Oncol. 2013 Jun 1;31(16):1977-83
pubmed: 23547079
Ann Oncol. 2013 Aug;24(8):2108-12
pubmed: 23585513
Leuk Lymphoma. 2013 Aug;54(8):1831-5
pubmed: 23621802
Blood. 2013 Nov 28;122(23):3759-66
pubmed: 24085766
Blood. 2014 Jan 16;123(3):334-7
pubmed: 24297868
Br J Haematol. 2014 Mar;164(5):710-6
pubmed: 24344981
Br J Haematol. 2014 Jul;166(1):50-9
pubmed: 24661013
Clin Cancer Res. 2014 Dec 15;20(24):6398-405
pubmed: 25316810
Br J Haematol. 2015 Aug;170(3):367-71
pubmed: 25858645
Blood. 2015 Jun 11;125(24):3679-87
pubmed: 25887775
J Clin Oncol. 2015 Aug 10;33(23):2516-22
pubmed: 26124482
Int J Lab Hematol. 2015 Dec;37(6):766-73
pubmed: 26189968
J Mol Diagn. 2015 Nov;17(6):652-60
pubmed: 26319783
Biol Blood Marrow Transplant. 2016 Feb;22(2):380-385
pubmed: 26348890
Leukemia. 2016 Apr;30(4):929-36
pubmed: 26639181
Methods Mol Biol. 2016;1392:43-50
pubmed: 26843045
Lancet Haematol. 2014 Oct;1(1):e17-27
pubmed: 27030064
Lab Med. 2016 May;47(2):103-11
pubmed: 27069028
Crit Rev Oncol Hematol. 2016 Jul;103:99-108
pubmed: 27262540
Lancet. 2016 Aug 6;388(10044):565-75
pubmed: 27313086
Ann Oncol. 2016 Dec;27(12):2149-2160
pubmed: 27701070
Front Pharmacol. 2016 Oct 13;7:363
pubmed: 27790140
Haematologica. 2017 Feb;102(2):e57-e60
pubmed: 27846615
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):437-445
pubmed: 27913513
Bone Marrow Transplant. 2017 Apr;52(4):544-551
pubmed: 27941777
Biol Blood Marrow Transplant. 2017 Mar;23(3):428-435
pubmed: 28039078
Leukemia. 2017 Oct;31(10):2094-2103
pubmed: 28104919
J Mol Diagn. 2017 May;19(3):437-444
pubmed: 28268092
Expert Rev Mol Diagn. 2017 Jun;17(6):557-566
pubmed: 28415895
Front Pharmacol. 2017 Jun 29;8:413
pubmed: 28706485
Blood. 2017 Sep 21;130(12):1409-1417
pubmed: 28720586
Rev Bras Hematol Hemoter. 2017 Jul - Sep;39(3):252-258
pubmed: 28830605
Ann Oncol. 2017 Jul 1;28(suppl_4):iv62-iv71
pubmed: 28881919
BMC Bioinformatics. 2017 Nov 23;18(1):516
pubmed: 29169317
Ann Oncol. 2018 Mar 1;29(3):544-562
pubmed: 29194473
Am J Surg Pathol. 1986 Nov;10(11):780-8
pubmed: 2946246
Haematologica. 2018 Jun;103(6):1029-1037
pubmed: 29567768
J Mol Diagn. 2018 Jul;20(4):474-482
pubmed: 29625246
Blood Adv. 2018 Apr 10;2(7):807-816
pubmed: 29636326
N Engl J Med. 2018 Apr 12;378(15):1396-1407
pubmed: 29641966
Best Pract Res Clin Haematol. 2018 Jun;31(2):135-146
pubmed: 29909914
Leuk Lymphoma. 2019 Feb;60(2):503-506
pubmed: 29966461
J Clin Oncol. 2018 Oct 1;36(28):2845-2853
pubmed: 30125215
Epigenomics. 2019 Jan;11(1):35-51
pubmed: 30211623
Blood. 2018 Dec 6;132(23):2456-2464
pubmed: 30249784
Ann Oncol. 2018 Dec 1;29(12):2363-2370
pubmed: 30307529
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):478-488
pubmed: 30382301
F1000Res. 2018 Dec 21;7:
pubmed: 30613381
Methods Mol Biol. 2019;1956:157-197
pubmed: 30779035
Methods Mol Biol. 2019;1956:199-228
pubmed: 30779036
Cancer Res Treat. 2019 Mar 12;:null
pubmed: 30913868
Cancer Med. 2019 May;8(5):2041-2055
pubmed: 30950237
Curr Opin Oncol. 1994 Sep;6(5):473-9
pubmed: 7530053
Hematol Oncol Clin North Am. 1993 Jun;7(3):577-90
pubmed: 8102135
N Engl J Med. 1993 Sep 30;329(14):987-94
pubmed: 8141877
Blood. 1994 Apr 1;83(7):1871-5
pubmed: 8142653
Blood. 1997 Jan 15;89(2):724-31
pubmed: 9002976
Blood. 1998 Aug 1;92(3):784-9
pubmed: 9680345
Leukemia. 1998 Dec;12(12):2006-14
pubmed: 9844931
Diagn Mol Pathol. 1998 Aug;7(4):209-14
pubmed: 9917131